Le Lézard
Classified in: Health, Sports and recreation
Subject: PER

Health and Fitness App 8fit Appoints Mark Ralea as CEO and Promotes Former VP Product Lisette Fabian to Co-CEO


BERLIN, Dec. 9, 2019 /PRNewswire/ -- 8fit, the leading health and fitness app, today announced that its board of directors has named both Mark Ralea and Lisette Fabian as the company's new leadership team, as CEO and co-CEO respectively. Ralea and Fabian bring nearly three decades of combined leadership experience to the young brand.

A digital industry veteran with 17 years of experience, Mark Ralea most recently led the transformation and expansion of STYLEBOP.com, a global e-commerce store for luxury fashion, as Managing Director. The company is now part of the German P&C Group. Prior to his role at STYLEBOP.com, Ralea served nearly six years at the international beauty subscription company GLOSSYBOX. As Chief Marketing Officer and later Managing Director at GLOSSYBOX, Ralea helped transform the brand into the first profitable business in the Rocket Internet network, resulting in its eventual acquisition by The Hut Group. From 2010 to 2012, Ralea led as Head of Marketing and Director Product of DailyDeal GmbH, which was acquired by Google Inc. in 2011.

"I am delighted to be joining 8fit at such a thrilling time for both the company and world of mobile, personalized fitness," said Ralea. "I'm honored to hold this position, eager to partner with Lisette and help elevate this pioneering brand."

Joining Ralea, Lisette Fabian has been with 8fit since January 2019 as VP of Product and will be taking on the role of co-CEO. Prior to joining 8fit, Lisette has held various roles within software development for over 20 years, supporting B2C & B2B businesses for global brands like Orbitz, Conversant, and Delivery Hero.

"Mark has the digital track record and breadth of leadership experience I believe will be paramount to building on 8fit's strong momentum," said Fabian. "I'm excited and proud to have an opportunity to work alongside Mark as we tackle new challenges and strive to evolve health and wellness through technology."

For more information about 8fit, please visit https://8fit.com/. To try 8fit for free for 14 days, visit the App Store or Google Play and download the app.

About 8fit

8fit simplifies healthy living by providing tailored guidance, custom workouts, and personalized meal plans in one easy-to-use mobile app. Designed to meet users at their level, 8fit is the quintessential tool for anyone striving for personal well-being. With hundreds of delicious, healthy recipes and workouts that can be done from home, 8fit has built a community of more than 20 million people worldwide. The company is based in Berlin and is funded by investors including Creandum and Eight Roads Ventures. 8fit is available for download on iOS and Android.

Media Contact:
Megan Brilley, IDPR for 8fit
230560@email4pr.com 
(949) 777-2486

SOURCE 8fit


These press releases may also interest you

at 09:15
Shionogi B.V., the European subsidiary of Shionogi & Co., Ltd. (Head Office: Osaka, Japan; President & CEO: Isao Teshirogi, Ph.D.; hereafter "Shionogi") today announce the publication of a new systematic review in CHEST Journal, funded by Shionogi...

at 09:15
Sansero Life Sciences, a leader in the development of psilocybin-based medicines, announced today that it has partnered with the University of Toronto to complete a preclinical study on the effects of low-dose psilocybin. The study will bring new...

at 09:12
Mind Cure Health Inc. ("Mind Cure" or the "Corporation") is pleased today to announce the addition of Dr. Dan Engle to the company's scientific advisory board. Dr. Dan Engle is a world-renowned physician in both psychiatry and neurology and sits at...

at 09:10
Clarigent Health, a mental health technology company, today announced the launch of Clairity, an app-based listening tool designed to provide clinical decision support to mental health professionals. Clairity analyzes speech with artificial...

at 09:10
Revelation Biosciences Inc. (Revelation), a clinical stage life sciences company focused on the development of immunologic-based therapies for the prevention and treatment of disease, announced today that it has been granted approval by the Bellberry...

at 09:10
Care Access Research, the leader in rapid development and management of high-performing clinical research sites, announced that it is collaborating with global healthcare leader Eli Lilly and Company. Care Access Research is helping Lilly manage the...



News published on 9 december 2019 at 08:31 and distributed by: